Evidence map›Paper›PMID 25384898›Full record

Trial reportRadiation oncology (London, England)2014

PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.

Christoph Oehler, Stephanie Lang, Peter Dimmerling, Christian Bolesch, Stephan Kloeck, Alessandra Tini, Christoph Glanzmann, Yousef Najafi, Gabriela Studer, Daniel R Zwahlen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Radiation oncology (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christoph OehlerDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. christoph.oehler@ksgr.ch.
Stephanie LangDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. stephanie.lang@usz.ch.
Peter DimmerlingDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. peter.dimmerling@usz.ch.
Christian BoleschDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. cbolesch@student.ethz.ch.
Stephan KloeckDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. stephan.kloeck@usz.ch.
Alessandra TiniDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. alessandra.tini@usz.ch.
Christoph GlanzmannDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. christoph.glanzmann@usz.ch.
Yousef NajafiDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. yousef.najafi@usz.ch.
Gabriela StuderDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. gabriela.studer@usz.ch.
Daniel R ZwahlenDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. daniel.zwahlen@gmx.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate PTV margins for hypofractionated IGRT of prostate comparing kV/kV imaging or CBCT. PATIENTS AND

methodsBetween 2009 and 2012, 20 patients with low- (LR), intermediate- (IR) and high-risk (HR) prostate cancer were treated with VMAT in supine position with fiducial markers (FM), endorectal balloon (ERB) and full bladder. CBCT's and kV/kV imaging were performed before and additional CBCT's after treatment assessing intra-fraction motion. CTVP for 5 patients with LR and CTVPSV for 5 patients with IR/HR prostate cancer were contoured independently by 3 radiation oncologists using MRI. The van Hark formula (PTV margin =2.5Σ +0.7σ) was applied to calculate PTV margins of prostate/seminal vesicles (P/PSV) using CBCT or FM.

results172 and 52 CBCTs before and after RT and 507 kV/kV images before RT were analysed. Differences between FM in CBCT or in planar kV image pairs were below 1 mm. Accounting for both random and systematic uncertainties anisotropic PTV margins were 5-8 mm for P (LR) and 6-11 mm for PSV (IR/HR). Random uncertainties like intra-fraction and inter-fraction (setup) uncertainties were of similar magnitude (0.9-1.4 mm). Largest uncertainty was introduced by CTV delineation (LR: 1-2 mm, IR/HR: 1.6-3.5 mm). Patient positioning using bone matching or ERB-matching resulted in larger PTV margins.

conclusionsFor IGRT CBCT or kV/kV-image pairs with FM are interchangeable in respect of accuracy. Especially for hypofractionated RT, PTV margins can be kept in the range of 5 mm or below if stringent daily IGRT, ideally including prostate tracking, is applied. MR-based CTV delineation optimization is recommended.

Indexed as

Dose Fractionation, RadiationFiducial MarkersCone-Beam Computed TomographyFollow-Up StudiesHumansMalePatient PositioningProstatic NeoplasmsRadiotherapy, Image-GuidedRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-Assisted

Identifiers

PMID25384898
PMCPMC4229608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.